Thesis Based on Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)’s imminent catalysts (Reproxalap), considering the company holds $133 million in cash, cash equivalents and marketable securities, as
Marvell Technology (NASDAQ:MRVL) is a key supplier of data center infrastructure semiconductor solutions for data center core and network edge. Marvell’s data center business